TITLE

Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients

AUTHOR(S)
Valantin, M. A.; Bittar, R.; de Truchis, P.; Bollens, D.; Slama, L.; Giral, P.; Bonnefont-Rousselot, D.; Pétour, P.; Aubron-Olivier, C.; Costagliola, D.; Katlama, C.
PUB. DATE
March 2010
SOURCE
Journal of Antimicrobial Chemotherapy (JAC);Mar2010, Vol. 65 Issue 3, p556
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: To assess the impact of switching to tenofovir disoproxil fumarate + emtricitabine on lipid parameters.
ACCESSION #
48045047

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics